Sentinel Oncology was founded in 2005 in Cambridge, UK and is a drug discovery company dedicated to the development and commercialisation of new therapeutics to treat patients for whom there is currently an unmet medical need.
Watch the video below for more information:
https://youtu.be/AxRlQZv4YMo
For more information about o2h ventures portfolio companies click here
Sign up to our IFA Magazine newsletter to keep up to date.
Cash ISA interest rates are climbing sharply as a torrent of deposits flood the market, giving savers a powerful window…
![[UNS] celebrate](https://ifamagazine.com/wp-content/uploads/wordpress-popular-posts/801986-featured-300x200.webp)
Two Premium Bonds holders from Leeds and Cheshire & West Chester are celebrating an unforgettable start to summer af…
Insurance and Protection, Insurance and Protection Magazine
As we move into the summer months, protection advice continues to evolve at pace. From changing healthcare expectations…
New calculations* from Quilter, the wealth manager and financial adviser, reveal that a single person now requires a pen…
Hargreaves Lansdown (HL), confirms its participation in the SpaceX initial public offering (IPO). HL’s two million custo…
Charlene Young, senior pensions and savings expert at AJ Bell, examines the strong rush into Cash ISAs at the start of t…
A Freedom of Information (FOI) request to HMRC by LCP Partner Steve Webb has revealed that more than 2.8m workers are ex…
In this week’s episode of IFA Talk, the weekly podcast from IFA Magazine, we unpack intergenerational wealth transfers a…
UK house price growth slowed in May, according to Nationwide’s latest House Price Index, with prices falling by 0.6% mon…
Guardian is reporting today that it will expand its Essentials range, which is designed for clients who want quality cov…
IFA Talk is our flagship podcast, that fits perfectly into your busy life, bringing the latest insight, analysis, news and interviews to you, wherever you are.
